High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial Meeting Abstract

  

Authors:	Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
Abstract Title:	High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
Meeting Title:	51st Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title:	Pediatric Blood and Cancer
Volume:	66
Issue:	Suppl. 4
Meeting Dates:	2019 Oct 23-26
Meeting Location:	Lyon, France
ISSN:	1545-5009
Publisher:	Wiley Periodicals, Inc
Date Published:	2019-12-01
Start Page:	S332
Language:	English
ACCESSION:	WOS:000488458004022
PROVIDER:	wos
PUBMED:	31568621
DOI:	10.1002/pbc.27989
Notes:	Meeting Abstract: V348 SIOP19-1007 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156524